Publication | Closed Access

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2

Medicinal ChemistryDrug TargetingMedicineRational Drug DesignAnti-cancer AgentDrug DevelopmentNovel 4-Methoxyphenyl PyrazolePharmacologyRadiation OncologySar StudiesDrug DiscoveryPyrimidine Derivatives